Irem Rami
Irem brings over a decade of investing and operating experience across various stages of healthcare services and healthcare technology companies. At Norwest, she focuses on venture and growth equity opportunities across healthcare services, healthcare IT, pharma services, and digital health. Prior to joining Norwest, Irem worked at Summit Partners where she focused on healthcare growth […]
Zack Scott, MD
Dr. Zack Scott previously served on the board of directors for Cianna Medical, Coherex Medical, Evidation Health, Providence Medical Technology, Respicardia, Spiration, and Syapse. Prior to joining Norwest, Zack was the co-founder and managing partner of Revelation Partners, a dedicated secondary investor specializing in shareholder liquidity and growth capital for healthcare companies. During his time […]
Brian Matesic, MD
Brian is an experienced life sciences investor who focuses on early to mid-stage companies. Prior to joining Norwest, Brian worked at Blackstone Life Sciences, where he helped lead over $1.5B of investments across biotech, medical devices, and diagnostics. He was a Board Observer or Alliance Committee Member at 5 companies, working closely with management teams […]
Tiba Aynechi, PhD
Tiba joins Norwest as a biotech investor with 20+ years of research and investment experience. She invests in healthcare with a focus on early to mid-stage companies within the therapeutics sector. Prior to joining Norwest, Tiba spent over ten years at Novo Holdings A/S, one of the top life sciences investment firms, with offices in […]
Suraj Shah
Suraj focuses on venture opportunities in the healthcare sector, including digital health and healthcare IT, technology-enabled healthcare services, medical devices, diagnostics, and biopharma. Prior to joining Norwest, Suraj was a senior business analyst in the healthcare practice at Kearney, a global management consulting firm. Prior to Kearney, he held a business development role at UnitedHealthGroup. […]
